Investor Conference Call: Telix’s acquisition of TheraPharm GmbH
Melbourne (Australia) – 30th November 2020. Telix advises it will hold an investor conference call to provide further detail in relation to Telix’s acquisition of TheraPharm GmbH.
Telix Pharmaceuticals Limited will hold an investor conference call at 8:00am AEDT on Tuesday 1st December to provide further detail in relation to Telix’s acquisition of TheraPharm GmbH.
Participants can register for the conference call by navigating to:
Please note that registered participants will receive their dial in number upon registration.